<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05047146</url>
  </required_header>
  <id_info>
    <org_study_id>00246/2021</org_study_id>
    <nct_id>NCT05047146</nct_id>
  </id_info>
  <brief_title>The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt</brief_title>
  <official_title>The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sadat City University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sadat City University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed at study the clinical and pathological criteria of Hepatocellular carcinoma&#xD;
      to keep with new challenging in diagnosis and morpho-molecular classifications&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinicopathological factors of Hepatocellular Carcinoma</measure>
    <time_frame>10 years</time_frame>
    <description>Serum alpha-fetoprotein (AFP) level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinicopathological factors of Hepatocellular Carcinoma</measure>
    <time_frame>10 years</time_frame>
    <description>Tumor size and focality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinicopathological factors of Hepatocellular Carcinoma</measure>
    <time_frame>10 years</time_frame>
    <description>Vascular invasion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinicopathological factors of Hepatocellular Carcinoma</measure>
    <time_frame>10 years</time_frame>
    <description>Pathologic stage and grade</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinicopathological factors of Hepatocellular Carcinoma</measure>
    <time_frame>10 years</time_frame>
    <description>The reserve of background liver</description>
  </primary_outcome>
  <enrollment type="Anticipated">530</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Morphological classifications of HCC</intervention_name>
    <description>Morphological classifications of Hepatocellular carcinoma</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        HCC cases from a single tertiary center eligible for pathological analysis as a primary&#xD;
        tool&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All pathologically proven Hepatocellular Carcinoma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other malignant tumors than Hepatocellular Carcinoma&#xD;
&#xD;
          -  Benign tumor&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Liver Intitute</name>
      <address>
        <city>ShibÄ«n Al Kawm</city>
        <state>Menoufia</state>
        <zip>32511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dina Mohamed Sweed, MD</last_name>
      <phone>01015007205</phone>
      <email>dina.sweed@liver.menofia.edu.eg</email>
    </contact>
    <investigator>
      <last_name>Dina Mohamed Sweed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 2, 2021</study_first_submitted>
  <study_first_submitted_qc>September 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sadat City University</investigator_affiliation>
    <investigator_full_name>Mahmoud Samy Abdallah</investigator_full_name>
    <investigator_title>Lecturer of Clinical Pharmacy</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>sharing will be by website or google after paper publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

